Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
The applicant stated that C1763 is indicated for treating urinary incontinence resulting from hypermobility or Intrinsic Sphincter Deficiency (ISD), pelvic floor repair, [or implantation] to reinforce soft tissues where weakness exists in the urological or musculoskeletal anatomy
Notice All products offered by Sisterly Strategiez Labs are sold strictly for laboratory research and in-vitro analytical purposes only
Peptide library approach to uncover phosphomimetic inhibitors of the BRCA1 C-terminal domain
This step-up approach is commonly referenced in peptide education materials to support a more progressive dosing model
For 2025, claims data for CPT code 0810T was not yet available
US$ 25.97
US$ 21.73
US$ 29.10
US$ 27.52
US$ 20.73
US$ 20.05
US$ 25.39
US$ 26.73
